ATL expects flat Q3 revenues

Article

Ultrasound vendor ATL reported lastweek that it is not expecting any improvement in third-quarterrevenues due to ongoing difficult market conditions in the U.S.and Europe. According to preliminary internal estimates conductedby the Bothell, WA-based

Ultrasound vendor ATL reported lastweek that it is not expecting any improvement in third-quarterrevenues due to ongoing difficult market conditions in the U.S.and Europe. According to preliminary internal estimates conductedby the Bothell, WA-based company, third-quarter revenues willprobably be similar to, but will not exceed, those of the secondquarter of this year. ATL reported second-quarter revenue of $84.8million, down 5% compared to the same period a year ago (SCAN8/10/94).

ATL is pinning hopes for a recovery in part on Apogee 800,a mid-range scanner acquired through the vendor's merger withInterspec. ATL is in the midst of a worldwide roll-out of theproduct.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.